Endoscopic papillary balloon dilation can be safely performed in patients with dual antiplatelet therapy: A pilot study
Authors:
Preprint
- 1 November 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Endoscopic papillary balloon dilation (EPBD)—a low-risk procedure for bleeding—has been suggested as an alternative to endoscopic sphincterotomy (EST) for papillary dilatation in patients undergoing choledocholithotomy and at a high risk of bleeding. Several guidelines recommend dual antiplatelet therapy (DAPT) be reduced to single antiplatelet therapy (SAPT) when EST is performed. However, there is no evidence that EPBD increases the risk of bleeding in patients receiving DAPT. Thus, we aimed to address this problem. We included 31 patients who underwent EPBD for CBD stones and received DAPT or SAPT prior to EPBD (9 in the DAPT group and 22 in the SAPT group) treated at our hospital from May 2014 to August 2022. The DAPT group included patients who underwent EPBD without antiplatelet therapy withdrawal or with a shorter withdrawal period than those recommended by the guidelines. In the DAPT group, one of the two antiplatelet agents used was thienopyridine. No bleeding was observed after EPBD in this study. We did not find any significant between-group differences in the change in hemoglobin levels and post-ERCP pancreatitis. Thus, we propose that EPBD does not increase the bleedingrisk in patients with DAPT.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Bleeding after endoscopic sphincterotomy or papillary balloon dilation among users of antithrombotic agentsEndoscopy, 2015
- Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) studyEndoscopy, 2015
- Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatmentDigestive Endoscopy, 2013
- Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomyWorld Journal of Gastroenterology, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Endoscopic Papillary Balloon Dilation for Bile Duct Stone: Immediate and Long-Term Outcomes in 1000 PatientsClinical Gastroenterology and Hepatology, 2007
- Antiplatelet Therapy and the Risk of Bleeding Induced by Gastrointestinal Endoscopic ProceduresDigestion, 2007
- The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents – a case–control studyAlimentary Pharmacology & Therapeutics, 2006
- Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trialGastrointestinal Endoscopy, 2003
- Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stonesThe Lancet, 1997